XTL BIOPHARMACEUTICALS LTD. Settlements Fair Value Measurement Liabilities
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Settlements Fair Value Measurement Liabilities of $926.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:SettlementsFairValueMeasurementLiabilities · last filed 2025-04-30
| Period end | Settlements Fair Value Measurement Liabilities 12 month | Settlements Fair Value Measurement Liabilities 12 month as first filed |
|---|---|---|
| 2024-12-31 | $926.00K 20-F · filed 2025-04-30 | |
| 2022-12-31 | $1.05M 20-F · filed 2025-04-30 | |
| 2018-12-31 | $974.00K 20-F · filed 2021-03-15 | -$974.00K 20-F · filed 2019-03-11 |
| 2017-12-31 | $765.00K 20-F · filed 2020-03-12 | -$765.00K 20-F · filed 2018-03-15 |